US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Osiris Therape (MM) (OSIR)
Osiris Therape (MM) (OSIR) ニュース

OSIR

Osiris Therapeutics, Inc. (OSIR)

Osiris Therape (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OSIR

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2019/04/30	05 : 13	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/17	22 : 48	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/17	22 : 37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/17	22 : 37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/17	22 : 36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/17	22 : 19	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/17	22 : 18	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/17	22 : 18	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/17	22 : 18	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/17	22 : 18	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/17	22 : 15	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/17	22 : 05	GlobeNewswire Inc.	Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/17	19 : 08	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/17	19 : 08	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/16	22 : 02	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/12	21 : 57	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/10	22 : 34	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:OSIR	Osiris Therape (MM)
2019/04/10	22 : 30	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:OSIR	Osiris Therape (MM)
2019/03/28	06 : 20	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:OSIR	Osiris Therape (MM)
2019/03/28	06 : 13	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:OSIR	Osiris Therape (MM)
2019/03/20	20 : 43	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:OSIR	Osiris Therape (MM)
2019/03/20	20 : 33	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:OSIR	Osiris Therape (MM)
2019/03/16	07 : 13	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates Osiris Therapeutics, Inc.	NASDAQ:OSIR	Osiris Therape (MM)
2019/03/15	22 : 03	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:OSIR	Osiris Therape (MM)
2019/03/13	06 : 10	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:OSIR	Osiris Therape (MM)
2019/03/13	06 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OSIR	Osiris Therape (MM)
2019/03/13	06 : 03	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:OSIR	Osiris Therape (MM)
2019/03/13	02 : 14	PR Newswire (US)	ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Osiris Therapeutics, Inc.	NASDAQ:OSIR	Osiris Therape (MM)
2019/03/12	22 : 33	PR Newswire (US)	Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.	NASDAQ:OSIR	Osiris Therape (MM)
2019/03/12	22 : 22	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:OSIR	Osiris Therape (MM)

Showing the most relevant articles for your search:NASDAQ:OSIR

1 2 3 4 5 6 7 8 9 10 次へ >>

Bank of America

US Dollar vs Sterling

Financial Select Sector

US Dollar vs Euro

Energy Select Sector SPDR

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約